Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1905 1
1912 1
1917 1
1923 1
1927 1
1928 1
1931 1
1932 2
1936 3
1937 2
1938 4
1939 4
1940 1
1942 2
1944 1
1945 5
1946 15
1947 14
1948 21
1949 15
1950 31
1951 23
1952 32
1953 43
1954 34
1955 35
1956 35
1957 50
1958 38
1959 44
1960 26
1961 32
1962 49
1963 84
1964 102
1965 73
1966 66
1967 79
1968 83
1969 93
1970 111
1971 119
1972 117
1973 94
1974 109
1975 83
1976 72
1977 104
1978 74
1979 87
1980 84
1981 74
1982 89
1983 102
1984 86
1985 117
1986 112
1987 103
1988 118
1989 135
1990 104
1991 135
1992 124
1993 142
1994 157
1995 157
1996 171
1997 157
1998 173
1999 150
2000 181
2001 171
2002 218
2003 207
2004 220
2005 252
2006 254
2007 251
2008 291
2009 298
2010 314
2011 347
2012 407
2013 363
2014 390
2015 387
2016 475
2017 471
2018 511
2019 551
2020 647
2021 730
2022 740
2023 705
2024 556

Text availability

Article attribute

Article type

Publication date

Search Results

13,370 results

Results by year

Filters applied: . Clear all
Page 1
Juvenile Dermatomyositis-Clinical Phenotypes.
Li D, Tansley SL. Li D, et al. Curr Rheumatol Rep. 2019 Dec 11;21(12):74. doi: 10.1007/s11926-019-0871-4. Curr Rheumatol Rep. 2019. PMID: 31828535 Free PMC article. Review.
PURPOSE OF REVIEW: Juvenile dermatomyositis is a heterogeneous disease with variable clinical outcomes. Here, we describe the recognised subtypes of idiopathic inflammatory myositis which occur in children, with particular reference to disease-associated autoantibodies. .. …
PURPOSE OF REVIEW: Juvenile dermatomyositis is a heterogeneous disease with variable clinical outcomes. Here, we describe the recogni …
Juvenile dermatomyositis. Where are we now?
McCann LJ, Livermore P, Wilkinson MGL, Wedderburn LR. McCann LJ, et al. Clin Exp Rheumatol. 2022 Feb;40(2):394-403. doi: 10.55563/clinexprheumatol/56ilob. Epub 2022 Feb 7. Clin Exp Rheumatol. 2022. PMID: 35225221 Free article. Review.
This review will focus on recent developments in understanding and treatment of juvenile dermatomyositis (JDM), the most common disease sub-type of IIM in childhood. JDM is a systemic immune mediated vasculopathy, increasingly recognised as a group of distinct phenotypes w …
This review will focus on recent developments in understanding and treatment of juvenile dermatomyositis (JDM), the most common disea …
Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
Leung AKC, Lam JM, Alobaida S, Leong KF, Wong AHC. Leung AKC, et al. Curr Pediatr Rev. 2021;17(4):273-287. doi: 10.2174/1573396317666210426105045. Curr Pediatr Rev. 2021. PMID: 33902423 Review.
OBJECTIVE: The purpose of this article is to provide readers with an update on the evaluation, diagnosis, and the treatment of juvenile dermatomyositis. METHODS: A PubMed search was performed in Clinical Queries using the key term "juvenile dermatomyositis" in the s …
OBJECTIVE: The purpose of this article is to provide readers with an update on the evaluation, diagnosis, and the treatment of juvenile d …
Dermatomyositis.
O'Connell KA, LaChance AH. O'Connell KA, et al. N Engl J Med. 2021 Jun 24;384(25):2437. doi: 10.1056/NEJMicm2033425. N Engl J Med. 2021. PMID: 34161709 No abstract available.
[Anti-MDA5 dermatomyositis. Literature review].
Castro-Molina SA, Méndez-Flores S. Castro-Molina SA, et al. Rev Med Inst Mex Seguro Soc. 2023 Jan 2;61(1):99-105. Rev Med Inst Mex Seguro Soc. 2023. PMID: 36542793 Free PMC article. Review. Spanish.
Dermatomyositis positive anti-melanoma differentiation-associated gene 5 (anti-MDA5 DM) is a rare disease that represents less than 2%. ...The clinical picture may be variable and is accompanied by the typical features of dermatomyositis, such as periorbital heliotr …
Dermatomyositis positive anti-melanoma differentiation-associated gene 5 (anti-MDA5 DM) is a rare disease that represents less than 2 …
Dermatomyositis.
Chu LL, Rohekar G. Chu LL, et al. CMAJ. 2019 Mar 25;191(12):E340. doi: 10.1503/cmaj.180947. CMAJ. 2019. PMID: 30910882 Free PMC article. No abstract available.
Current diagnosis and treatment of polymyositis and dermatomyositis.
Sasaki H, Kohsaka H. Sasaki H, et al. Mod Rheumatol. 2018 Nov;28(6):913-921. doi: 10.1080/14397595.2018.1467257. Epub 2018 May 9. Mod Rheumatol. 2018. PMID: 29669460 Review.
Idiopathic inflammatory myopathies (IIMs) are heterogeneous disorders that affect the skeletal muscles. Polymyositis, dermatomyositis, and inclusion body myositis are major IIM subsets. Immune-mediated necrotizing myopathy became recognized as a potentially new IIM subset. …
Idiopathic inflammatory myopathies (IIMs) are heterogeneous disorders that affect the skeletal muscles. Polymyositis, dermatomyositis …
Paraneoplastic Dermatomyositis.
Orton C, Topham C, Madigan LM. Orton C, et al. Am J Med. 2022 Aug;135(8):969-971. doi: 10.1016/j.amjmed.2022.01.016. Epub 2022 Feb 24. Am J Med. 2022. PMID: 35219689 No abstract available.
Dermatomyositis.
Mahil S, Marks D, McCormack M, Rahman A. Mahil S, et al. Br J Hosp Med (Lond). 2012 Feb;73(2):C18-22. doi: 10.12968/hmed.2012.73.sup2.c18. Br J Hosp Med (Lond). 2012. PMID: 22504710 Review.
Dermatomyositis is an idiopathic acute inflammatory disorder, characterized by inflammation of skeletal muscle, progressive symmetrical proximal myopathy and classical cutaneous manifestations. It affects both children and adults, and women more frequently than men. Der …
Dermatomyositis is an idiopathic acute inflammatory disorder, characterized by inflammation of skeletal muscle, progressive symmetric …
Update on dermatomyositis in adults.
Schlecht N, Sunderkötter C, Niehaus S, Nashan D. Schlecht N, et al. J Dtsch Dermatol Ges. 2020 Sep;18(9):995-1013. doi: 10.1111/ddg.14267. J Dtsch Dermatol Ges. 2020. PMID: 32985813 Review.
Dermatomyositis (DM) in adults has a prevalence of 6-7 per 100,000 population per year. This dedicated compact overview was prepared due to an increasing incidence as well as an often underestimated systemic involvement and new developments in myositis-specific antibodies …
Dermatomyositis (DM) in adults has a prevalence of 6-7 per 100,000 population per year. This dedicated compact overview was prepared …
13,370 results
You have reached the last available page of results. Please see the User Guide for more information.